-
-
Call more information
660-596-2224 -
With more pain patients turning to medical marijuana (and recreational cannabis) to ease their discomfort, clinicians might want to consider issues pertaining to driving and working while under the influence. Gerald Aronoff, MD, medical director, Carolina Pain Associates, and medical director, North American Pain & Disability Group, Charlotte, North Carolina, doesn’t prescribe opiates to his […]
Read MoreA noninvasive, easy-to-administer sphenopalatine ganglion block relieves postdural puncture headache (PDPH) faster than an epidural blood patch in obstetric patients and has fewer adverse effects, new research shows. The block works so well in patients with PDPH that it should the considered the first line treatment in this population, said Preet Patel, MD, Department of […]
Read MoreAdding the atypical antipsychotic drug olanzapine to a patient’s therapeutic regimen might help ease their refractory pain, a new systematic review suggests. Although not US Food and Drug Administration (FDA)–approved for pain, and not traditionally considered an analgesic, olanzapine has the strongest evidence for pain control of all the atypical antipsychotics, according to the review. […]
Read MoreA patient was in a motor vehicle accident that shattered his right leg. He started taking morphine extended-release tablets (MS Contin, Purdue Pharma) at a dose of 100 mg up to three times daily with escalating doses over 4 years, but he still had persistent back and leg pain that he rated a 10 on […]
Read MoreA procedure that involves radiofrequency ablation of sensory nerves in the degenerated lumbar disc may give many patients with chronic low back pain significant relief. Researchers have now collected up to 12 months of data on patients undergoing the procedure — called intradiscal biacuplasty (IDB) — and it shows improved pain scores, functioning, and quality […]
Read More